Kenneth D. Bruce

7.7k citations

106 papers · 5.3k indexed · h-index 42

Molecular Biology top 5%
Pulmonary and Respiratory Medicine top 1%
Ecology top 2%
Epidemiology top 5%
Emergency Medical Services top 0.5%

Co-authors: Geraint B. Rogers Mary P. Carroll David J. Serisier Peter Strike A. Mark Osborn Chris Gast D.A. Ritchie T. Daniels
Topics: Cystic Fibrosis Research Advances (37 papers)Gut microbiota and health (35 papers)Tracheal and airway disorders (15 papers)
Cited by: Emergency Medical Services Pulmonary and Respiratory Medicine Molecular Medicine
Journals: Science The Journal of Immunology PLoS ONE
Partner nations: United Kingdom Australia United States

In The Last Decade

Kenneth D. Bruce

105 papers receiving 5.2k citations

Peers

Countries citing papers authored by Kenneth D. Bruce

Since Specialization

Citations

This map shows the geographic impact of Kenneth D. Bruce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth D. Bruce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth D. Bruce more than expected).

Fields of papers citing papers by Kenneth D. Bruce

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth D. Bruce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth D. Bruce. The network helps show where Kenneth D. Bruce may publish in the future.

Co-authorship network of co-authors of Kenneth D. Bruce

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth D. Bruce. A scholar is included among the top collaborators of Kenneth D. Bruce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth D. Bruce. Kenneth D. Bruce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bacterial diversity, viability and stability in lyophilised faecal microbiota capsules support ongoing clinical use 2025 ·International Journal of Pharmaceutics ·Nur Masirah M. Zain,Blair Merrick,(unknown),Lindsey Edwards,(unknown),Sophia Tsoka,A. James Mason,Grace B. Hatton,Elizabeth Allen,Paul G. Royall,Andrew Lilley,Kenneth D. Bruce,Debbie L. Shawcross,Simon Goldenberg,Ben Forbes	1
2	Architectural immunity: Ants alter their nest networks to prevent epidemics 2025 ·Science ·(unknown),(unknown),Kenneth D. Bruce,Nathalie Stroeymeyt	1
3	Development of Novel Membrane Disrupting Lipoguanidine Compounds Sensitizing Gram-Negative Bacteria to Antibiotics 2024 ·ACS Medicinal Chemistry Letters ·(unknown),Charlotte K. Hind,Guilherme Fernandes,(unknown),(unknown),Melanie Clifford,(unknown),(unknown),A. James Mason,Kenneth D. Bruce,J. Mark Sutton,Daniele Castagnolo	1
4	Porphyromonas pasteri and Prevotella nanceiensis in the sputum microbiota are associated with increased decline in lung function in individuals with cystic fibrosis 2022 ·Journal of Medical Microbiology ·(unknown),Nur Masirah M. Zain,Iain Stewart,Andrew Fogarty,E.F. Nash,J.L. Whitehouse,Alan R Smyth,Andrew Lilley,Alan J. Knox,Paul Williams,Miguel Cámara,Kenneth D. Bruce,H. Barr	9
5	Antibiotic-in-Cyclodextrin-in-Liposomes: Formulation Development and Interactions with Model Bacterial Membranes 2020 ·Molecular Pharmaceutics ·(unknown),(unknown),Margarita Valero,Gustavo González‐Gaitano,(unknown),Nur Masirah M. Zain,Kenneth D. Bruce,Luke A. Clifton,Maximilian W. A. Skoda,Khondaker Miraz Rahman,Richard D. Harvey,Cécile A. Dreiss	11
6	The small quinolone derived compound HT61 enhances the effect of tobramycin against Pseudomonas aeruginosa in vitro and in vivo 2019 ·Pulmonary Pharmacology & Therapeutics ·Richard T. Amison,(unknown),(unknown),Kenneth D. Bruce,Yanmin Hu,Anthony Coates,Clive Page	5
7	Three Clinically Distinct Chronic Pediatric Airway Infections Share a Common Core Microbiota 2014 ·Annals of the American Thoracic Society ·Chris Gast,Leah Cuthbertson,Geraint B. Rogers,Christopher E. Pope,Robyn L. Marsh,Gregory J. Redding,Kenneth D. Bruce,Anne B. Chang,Lucas R. Hoffman	68
8	Environmentally Determined Differences in the Murine Lung Microbiota and Their Relation to Alveolar Architecture 2014 ·PLoS ONE ·Yeojun Yun,G. Srinivas,Sven Küenzel,Miriam Linnenbrink,(unknown),Kenneth D. Bruce,Ulrich Steinhoff,John F. Baines,Ulrich E. Schaible	112
9	Staphylococcus aureus Small-Colony Variants Are Independently Associated With Worse Lung Disease in Children With Cystic Fibrosis 2013 ·Clinical Infectious Diseases ·Daniel J. Wolter,Julia Emerson,Sharon McNamara,Anne Marie Buccat,Xuan Qin,Elizabeth Cochrane,Laura S. Houston,Geraint B. Rogers,Peter Marsh,(unknown),Christopher E. Pope,Marcella Blackledge,Éric Déziel,Kenneth D. Bruce,Bonnie W. Ramsey,Ronald L. Gibson,Jane L. Burns,Lucas R. Hoffman	134
10	A relationship between Pseudomonal growth behaviour and cystic fibrosis patient lung function identified in a metabolomic investigation 2013 ·Metabolomics ·Justyna Kozłowska,Damian Rivett,Louic S. Vermeer,Mary P. Carroll,Kenneth D. Bruce,A. James Mason,Geraint B. Rogers	16
11	Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation? 2011 ·Journal of Cystic Fibrosis ·Franziska A. Stressmann,Geraint B. Rogers,Peter Marsh,Andrew Lilley,T. Daniels,Mary P. Carroll,Lucas R. Hoffman,Graeme Jones,(unknown),Nilesh Patel,Benjamin Forbes,Andrew Tuck,Kenneth D. Bruce	102
12	Cyclic antimicrobial R-, W-rich peptides: the role of peptide structure and E. coli outer and inner membranes in activity and the mode of action 2011 ·European Biophysics Journal ·(unknown),Richard D. Harvey,Kenneth D. Bruce,R. Dölling,Mojtaba Bagheri,Margitta Dathe	45
13	Using bacterial biomarkers to identify early indicators of cystic fibrosis pulmonary exacerbation onset 2011 ·Expert Review of Molecular Diagnostics ·Geraint B. Rogers,Lucas R. Hoffman,Matt Johnson,Nicole Mayer-Hamblett,Jürgen Schwarze,Mary P. Carroll,Kenneth D. Bruce	15
14	The exclusion of dead bacterial cells is essential for accurate molecular analysis of clinical samples 2010 ·Clinical Microbiology and Infection ·Geraint B. Rogers,Peter Marsh,Franziska A. Stressmann,Charles E. Allen,(unknown),M. P. Carroll,Kenneth D. Bruce	64
15	Modelling the bacterial communities associated with cystic fibrosis lung infections 2010 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown),M. P. Carroll,Andrew Lilley,(unknown),Kenneth D. Bruce	5
16	Determining the Effects of a Spatially Heterogeneous Selection Pressure on Bacterial Population Structure at the Sub-millimetre Scale 2010 ·Microbial Ecology ·Frances R. Slater,Kenneth D. Bruce,Richard J. Ellis,Andrew Lilley,Sarah L. Turner	8
17	Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy 2010 ·Trends in Microbiology ·Geraint B. Rogers,Lucas R. Hoffman,Marvin Whiteley,T. Daniels,Mary P. Carroll,Kenneth D. Bruce	59
18	Assessing the diagnostic importance of nonviable bacterial cells in respiratory infections 2008 ·Diagnostic Microbiology and Infectious Disease ·Geraint B. Rogers,Franziska A. Stressmann,Garrit Koller,T. Daniels,Mary P. Carroll,Kenneth D. Bruce	68
19	Terminal Restriction Fragment Length Polymorphism Monitoring of Genes Amplified Directly from Bacterial Communities in Soils and Sediments 2000 ·Molecular Biotechnology ·Kenneth D. Bruce,Mark Hughes	14
20	Characterisation of Haemophilus influenzae proteins by two‐dimensional gel electrophoresis 1995 ·Electrophoresis ·Phillip Cash,Evelyn Argo,Kenneth D. Bruce	42

About Kenneth D. Bruce

Kenneth D. Bruce is a scholar working on Pulmonary and Respiratory Medicine, Molecular Medicine and Emergency Medical Services, having authored 106 papers that have together received 5.3k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (37 papers), Gut microbiota and health (35 papers) and Tracheal and airway disorders (15 papers). The work is most often cited by research in Emergency Medical Services (574 citations), Pulmonary and Respiratory Medicine (2.0k citations) and Molecular Medicine (252 citations). Kenneth D. Bruce has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Geraint B. Rogers, Mary P. Carroll, David J. Serisier, Peter Strike, A. Mark Osborn, Chris Gast, D.A. Ritchie, T. Daniels, Lucas R. Hoffman and Franziska A. Stressmann. Their work appears in journals such as Science, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact